Skip to content

Wound Powder for Pressure Ulcers at End-of-life

Novel Wound Powder RGN107 to Reduce Wound Odor, Pain and Exudate at End-of-life

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008487
Acronym
RGN107
Enrollment
50
Registered
2013-12-11
Start date
2013-04-30
Completion date
2016-03-31
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcer, Wounds

Keywords

wound, palliative care, hospice, pressure ulcers

Brief summary

This study will test a special powder for ulcers caused by a variety of conditions such as pressure that sometimes happen when a person is at the end of life. The powder will be applied to these ulcers to see if it helps with pain, odor and drainage (leakage). People who are being cared for by hospice or palliative care organizations will be invited to be in the study. The study will also find out if the powder is easy to use by caregivers as well as improving the comfort and quality of life of the person who has the ulcer.

Detailed description

Aim 1. In a comparative 2-group design, we will evaluate and compare the feasibility of the intervention through assessment in both settings (home-based and inpatient) on: 1. Adherence to RGN107 protocol by licensed care providers and/or family or other caregivers providing wound care; measures include implementation of procedures, frequency of dressing changes. 2. Reach, enrollment, disenrollment, acceptability, satisfaction; measures include difficulties with recruitment and enrollment, side effects such as burning, peri-wound skin irritation. 3. Usability issues such as powder ability to stick to wound and ease of use of applying powder. Aim 2. Estimate variability of outcome measurements and effect sizes and investigate the presence of a preliminary signal of clinical efficacy in two groups of hospice/home health/residential individuals receiving RGN107 in: 1. Physical wound symptoms outcomes, specifically pain, odor and exudate. 2. Quality of life of individuals receiving and caregivers using RGN107.

Interventions

OTHERWound powder application

Powder application to wound per protocol.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 105 Years
Healthy volunteers
No

Inclusion criteria

* Aged 21 years or older * Patient prognosis \> 1 month and \< 6 months * Pressure wounds * Pain or odor or exudate score \> 2 on VAS * Wound caregiver able to perform required protocol activities

Exclusion criteria

* Known allergies to Turmeric, Mint, Sandalwood * Using negative pressure wound therapy * Currently using topical creams or ointments applied to wound bed (powder will not adhere to these products) * Wound with eschar covering (powder will not stick)

Design outcomes

Primary

MeasureTime frameDescription
reach4 weeksreach, enrollment, disenrollment, acceptability, satisfaction; measures include difficulties with recruitment and enrollment, side effects such as burning, peri-wound skin irritation.
adherence4 weeksadherence to RGN107 protocol by licensed care providers and/or family or other caregivers providing wound care; measures include implementation of procedures, frequency of dressing changes.
usability4 weeksusability issues such as powder ability to stick to wound and ease of use of applying powder.

Secondary

MeasureTime frameDescription
symptoms4 weeksphysical wound symptoms outcomes, specifically pain, odor and exudate will be measured with visual analog scales
quality of life4 weeksquality of life of individuals receiving and caregivers using RGN107.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026